Page 3 - மருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Raigad: 90 suffer Remdesivir side-effects, use of brand suspended

Raigad: 90 suffer Remdesivir side-effects, use of brand suspended IANS / Updated: Apr 30, 2021, 19:33 IST Mumbai/Raigad: At least 90 Covid-19 patients in Maharashtras Raigad district, who were administered Remdesivir doses of a particular brand, developed severe side-effects following which the state government has imposed a temporary suspension on its use here, FDA Minister Rajendra Shingane said. The incident took place on Thursday in three hospitals in the district. The patients who were administered Remdesivir manufactured by the company Hetero Drugs had complained of side-effects, Shingane told IANS. The shocking incident came to light when some patients developed chills and others complained of varying degrees of fever or other issues which were immediately addressed by the district medical authorities.

Vinod tiwariRajendra shinganeMaharashtras raigadHetero drugsDrug price control orderவினோத் திவாரிராஜேந்திரா ஷின்கனேஹெடரொ மருந்துகள்மருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர்

90 suffer Remdesivir side-effects, Maharashtra suspends Covifor injection

90 suffer Remdesivir side-effects, Maharashtra suspends Covifor injection IANS 30 April 2021 The incident took place on Thursday in three hospitals in the district. The patients who were administered Remdesivir manufactured by the company Hetero Drugs had complained of side-effects, Shingane told IANS. The shocking incident came to light when some patients developed chills and others complained of varying degrees of fever or other issues which were immediately addressed by the district medical authorities. The situation is under control and the condition of all the patients is stable now. There is no cause for worry, the minister assured. A district official said that out of a particular Hetero batch of its Rendesivir brand Covifor injection, 120 patients were given the doses out of which a staggering 90 reported the side-effects, alarming the local medical authorities.

Vinod tiwariRajendra shinganeMaharashtras raigadHetero drugsDrug price control orderவினோத் திவாரிராஜேந்திரா ஷின்கனேஹெடரொ மருந்துகள்மருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர்

Writ petition filed to issue CL for Covid drugs, regulate vaccine prices

Writ petition filed to issue CL for Covid drugs, regulate vaccine prices SECTIONS Share Synopsis Non-governmental organisation Jan Swasthya Abhiyan (JSA) filed a writ petition in the Supreme Court, seeking a direction to the Union government to issue compulsory licences (CLs) for key Covid-19 drugs such as remdesivir, tocilizumab and favipiravir. Agencies Non-governmental organisation Jan Swasthya Abhiyan (JSA) filed a writ petition in the Supreme Court, seeking a direction to the Union government to issue compulsory licences (CLs) for key Covid-19 drugs such as remdesivir, tocilizumab and favipiravir. A CL will allow companies with capabilities to manufacture these drugs. The petitioner made the health ministry, the Drugs Controller General of India, National Pharma Pricing Authority and Department for Promotion of Industry and Internal Trade, among others, party to the matter. Another petition appealed to the court to intervene in releasing the technical know-how of vaccine

Andhra pradeshRajeshwari hariharanAnand groverJan swasthya abhiyanNational pharma pricing authoritySupreme courtGilead sciencesDepartment for promotion of industryDrugs controller generalInternal tradeDrug price control orderPatents actஆந்திரா பிரதேஷ்ஆனந்த் தோப்புஜான் ஸ்வஸ்தயா அபியன்உச்ச நீதிமன்றம்

Maha: Mega scare as 90 suffer Remdesivir side-effects, brand suspended

Maha: Mega scare as 90 suffer Remdesivir side-effects, brand suspended Maha: Mega scare as 90 suffer Remdesivir side-effects, brand suspended Last Updated: Fri, Apr 30th, 2021, 23:01:31hrs Mumbai: Sparking a mega health scare, at least 90 Covid-19 patients in Maharashtra s Raigad district, who were administered Remdesivir doses of a particular brand, developed severe side-effects following which the state government has imposed a temporary suspension on its use here, FDA Minister Rajendra Shingane said. The incident took place on Thursday in around three hospitals in the district. The patients who were administered Remdesivir manufactured by the company Hetero Drugs had complained of side-effects, Shingane told IANS.

Vaishali patilNidhi choudhariVinod tiwariCentral vigilance commissionHetero drugsRaigad collector nidhi choudhariDrug price control orderCentral vigilanceவைஷாலி பாட்டீல்நிதி சவுதாரிவினோத் திவாரிமைய லஞ்ச ஒழிப்பு தரகுஹெடரொ மருந்துகள்ரெய்காட் ஆட்சியர் நிதி சவுதாரிமருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர்மைய லஞ்ச ஒழிப்பு

If 2015 was the Year of the API , why is there a Remdesivir shortage six years later?

If 2015 was the Year of the API , why is there a Remdesivir shortage six years later?
businessinsider.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.in Daily Mail and Mail on Sunday newspapers.

Jammu and kashmirAdar poonawallaAatmanirbhar bharatSerum institute of indiaUnited statesDrug price control orderஜம்மு மற்றும் காஷ்மீர்அடார் பூனாவல்லசீரம் நிறுவனம் ஆஃப் இந்தியாஒன்றுபட்டது மாநிலங்களில்மருந்து ப்ரைஸ் கட்டுப்பாடு ஆர்டர்